Maria Luisa Biondi

About Diatech Pharmacogenetics

This author has not yet filled in any details.
So far Diatech Pharmacogenetics has created 1080 blog entries.

14 10, 2020

Federica Bertolini et. al., Second Primary Tumors in head and neck cancer patients: the importance of a “tailored” surveillance

Diatech Pharmacogenetics2020-11-03T11:53:39+01:00

28 09, 2020

Alpelisib and PIK3CA mutations: a new molecular targeted therapy for breast cancer is approved

Diatech Pharmacogenetics2020-10-01T10:04:40+02:00

28 09, 2020

Francesco Cortiula et. al., A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients

Diatech Pharmacogenetics2020-11-03T11:56:51+01:00

9 09, 2020

Magda Zanelli et. al., Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study

Diatech Pharmacogenetics2020-11-03T12:02:43+01:00

4 09, 2020

Pierina Navarria et. al., Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series

Diatech Pharmacogenetics2020-09-04T13:57:59+02:00

1 09, 2020

Umberto Malapelle et. al., Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study.

Diatech Pharmacogenetics2020-11-03T16:41:13+01:00

1 09, 2020

Roberta Minari et. al., Detection of EGFR-Activating and T790M Mutations by Liquid Biopsy in Patients with EGFR-Mutated Non-Small-Cell Lung Cancer Who Have Progressed to First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study

Diatech Pharmacogenetics2020-11-03T15:51:44+01:00

24 08, 2020

Diagnostic test for the detection of SARS-CoV-2 virus
Diagnostic test for the detection of SARS-CoV-2 virus

Events, News

Diagnostic test for the detection of SARS-CoV-2 virus

Diatech Pharmacogenetics2021-04-20T10:50:25+02:00

22 07, 2020

Francesca Spada et. al., Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysis

Diatech Pharmacogenetics2020-11-03T14:22:06+01:00

Previous 456 Next